Disease Registry Software Global Market Report 2025
상품코드:1855865
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 질병 등록 소프트웨어 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 13억 9,000만 달러에서 2025년에는 15억 5,000만 달러에 달하고, CAGR 11.6%로 확대될 것으로 보입니다. 기간 중 성장은 만성질환 부담 증가, 임상연구 및 임상시험 확대, 희귀질환 유병률 증가, 전자차단(EHR)의 급속한 보급, 만성질환 확산 등과 관련이 있습니다.
질병 등록 소프트웨어 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년까지 연평균 복합 성장률(CAGR) 11.2%로 확대되어 23억 8,000만 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 밸류베이스 케어 모델의 채용 확대, 실제 세계 증거(RWE)의 이용 확대, 정밀 의료 이니셔티브의 성장, 만성 질환 및 생활 습관병의 이환율 상승, 환자 중심의 건강 관리 중시 강화 등과 관련이 있습니다. 예측 기간 동안 주요 동향으로는 의료 IT 인프라의 발전, 원격 의료 및 원격 모니터링과의 통합, 사물인터넷(IoT) 장치 및 웨어러블과의 연결, 데이터 시각화 및 대시보드 강화, 데이터 보안 및 상호 운용성을 위한 블록체인 활용 등이 있습니다.
맞춤형 의료의 채용 확대가 질병 등록 소프트웨어 시장의 확대를 촉진할 것으로 예측됩니다. 맞춤형 의료는 개인의 유전적 체질, 라이프 스타일, 환경에 따라 치료와 예방을 사용자 정의하는 방법입니다. 이 변화는 유전적 돌연변이의 정확한 식별과 맞춤형 치료의 개발을 가능하게 하는 유전체학의 진보에 크게 뒷받침됩니다. 질병 등록 소프트웨어는 환자의 건강 데이터를 체계적으로 수집 및 관리함으로써 맞춤형 의료에 중요한 역할을 하고 있습니다. 이러한 시스템은 데이터에 대한 액세스와 분석을 간소화하고, 궁극적으로 환자의 결과를 향상시키고, 정밀 헬스케어 분야를 발전시킵니다. 예를 들어, 맞춤형 의료연합(Personalized Medicine Coalition)의 보고에 따르면, 미국 식품의약국은 2023년에 26개의 개별화 신약을 승인했는데, 이는 2022년보다 크게 증가했습니다. 그 결과, 맞춤형 의료의 채용 확대가 질병 등록 소프트웨어 수요를 촉진하고 있습니다.
질병 등록 소프트웨어 시장의 주요 기업은 결과를 추적하고 맞춤형 의료를 지원하도록 설계된 디지털 시스템을 포함한 환자 중심의 레지스트리 구축에 주력하고 있습니다. 디지털 등록은 환자의 건강 정보를 체계적으로 수집, 저장 및 관리하는 전자 플랫폼이며, 기존의 종이 기반 방법을 대체합니다. 예를 들어, 2025년 8월 미국 심장병학회(American College of Cardiology)는 가장 흔한 유전적 심혈관계 질환인 비대형 심근증(HCM)의 이해와 관리를 개선하기 위한 전국 규모의 디지털 등록인 CONNECT-HCM 레지스트리를 시작했습니다. 이 레지스트리는 여러 시설에 걸쳐 환자를 직접 등록하고 진단과 치료의 격차를 해결합니다. 이 레지스트리는 Arboretum의 Hugo Connect 플랫폼을 통해 레지스트리 데이터를 전자 의료 기록과 연결하여 연구자가 증상, 영상 진단 결과, 치료 및 결과를 장기간 추적할 수 있도록 합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 질병 등록 소프트웨어 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 질병 등록 소프트웨어 시장 : 성장률 분석
세계의 질병 등록 소프트웨어 시장 실적 : 규모와 성장, 2019-2024년
세계의 질병 등록 소프트웨어 시장 예측 : 규모와 성장, 2024-2029년, 2034F
세계의 질병 등록 소프트웨어 시장 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 질병 등록 소프트웨어 시장 : 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
독립형
통합형
세계의 질병 등록 소프트웨어 시장 : 데이터베이스별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
공공
상업용
세계의 질병 등록 소프트웨어 시장 : 전개 모드별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
On-Premise
클라우드 기반
세계의 질병 등록 소프트웨어 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
병원
정부기관
연구센터
제약기업
기타 최종 사용자
세계의 질병 등록 소프트웨어 시장 : 독립형 유형별 세분화, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
환자 등록 소프트웨어
인구 건강 등록 소프트웨어
조사 등록 소프트웨어
맞춤/단일 질환 등록 소프트웨어
세계의 질병 등록 소프트웨어 시장 : 통합형 유형별 세분화, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
전자 의료 기록(EHR) 통합 등록 소프트웨어
진료 관리 시스템 통합 등록 소프트웨어
임상 의사 결정 지원(CDS) 통합 등록 소프트웨어
의료 정보 교환(HIE) 통합 등록 소프트웨어
제7장 지역별/국가별 분석
세계의 질병 등록 소프트웨어 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 질병 등록 소프트웨어 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
질병 등록 소프트웨어 시장 : 경쟁 구도
질병 등록 소프트웨어 시장 : 기업 프로파일
Optum Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
IQVIA Holdings Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Syneos Health Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Epic Systems Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Premier Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
MRO Corp.
ImageTrend Inc.
Anju Software Inc.
BayaTree Inc.
Medrio Inc.
ArborMetrix Inc.
Cedaron Medical Inc.
Evado Pty. Ltd.
OpenClinica LLC
Dacima Software Inc.
Global Vision Technologies Inc.
Ordinal Data Inc.
Healthmonix LLC
Axis Clinical Software Inc.
Vanderbilt University
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
질병 등록 소프트웨어 시장(2029년) : 새로운 기회를 제공하는 국가
질병 등록 소프트웨어 시장(2029년) : 새로운 기회를 제공하는 부문
질병 등록 소프트웨어 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Disease registry software is a dedicated digital platform designed to gather, organize, and manage patient information related to specific diseases or medical conditions. It enables healthcare providers, researchers, and policymakers to track disease trends, evaluate treatment outcomes, maintain regulatory compliance, and support clinical decisions to enhance patient care and overall population health.
The primary categories of disease registry software are standalone and integrated. Standalone systems operate independently to collect, manage, and analyze disease-specific patient data without relying on hospital or clinic infrastructure. These databases can be public or commercial, with deployment options including on-premises and cloud-based models, and they serve hospitals, government agencies, research institutions, pharmaceutical companies, and other users.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The disease registry software market research report is one of a series of new reports from The Business Research Company that provides disease registry software market statistics, including the disease registry software industry global market size, regional shares, competitors with the disease registry software market share, detailed disease registry software market segments, market trends, and opportunities, and any further data you may need to thrive in the disease registry software industry. This disease registry software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The disease registry software market size has grown rapidly in recent years. It will grow from $1.39 billion in 2024 to $1.55 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be linked to the increasing burden of chronic diseases, expansion of clinical research and trials, rising prevalence of rare diseases, rapid adoption of electronic health records (EHRs), and the widespread occurrence of chronic conditions.
The disease registry software market size is expected to see rapid growth in the next few years. It will grow to $2.38 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be linked to the expanding adoption of value-based care models, increased use of real-world evidence (RWE), growth of precision medicine initiatives, rising incidence of chronic and lifestyle-related diseases, and stronger emphasis on patient-centered healthcare. Key trends during the forecast period include advancements in healthcare IT infrastructure, integration with telehealth and remote monitoring, connection with internet of things (IoT) devices and wearables, enhanced data visualization and dashboards, and use of blockchain for data security and interoperability.
The growing adoption of personalized medicine is expected to drive the expansion of the disease registry software market. Personalized medicine is an approach that customizes treatment and prevention based on an individual's genetic makeup, lifestyle, and environment. This shift is largely driven by advancements in genomics, which allow for the precise identification of genetic variations and the development of tailored treatments. Disease registry software plays a crucial role in personalized medicine by systematically gathering and managing patient health data, enabling the creation of personalized treatment plans and supporting improved clinical decision-making. These systems streamline access to and analysis of data, ultimately enhancing patient outcomes and advancing the field of precision healthcare. For instance, the Personalized Medicine Coalition reported that the U.S. Food and Drug Administration approved 26 new personalized medicines in 2023, a substantial increase from 2022. As a result, the growing adoption of personalized medicine is fueling the demand for disease registry software.
Leading companies in the disease registry software market are focusing on creating patient-centric registries, such as digital systems designed to track outcomes and support personalized care. Digital registries are electronic platforms that systematically collect, store, and manage patient health information, replacing traditional paper-based methods. For example, in August 2025, the American College of Cardiology launched the CONNECT-HCM Registry, a nationwide digital registry aimed at improving the understanding and management of hypertrophic cardiomyopathy (HCM), the most common genetic cardiovascular condition. This registry allows for direct patient enrollment across multiple centers, addressing gaps in diagnosis and care. It links registry data with electronic health records via Arboretum's Hugo Connect platform, enabling researchers to track symptoms, imaging results, treatments, and outcomes over time.
In November 2023, Health Catalyst Inc., a U.S.-based healthcare analytics company, acquired Electronic Registry Systems Inc. (ERS) to enhance its oncology registry capabilities. With this acquisition, Health Catalyst integrates ERS's cancer data management expertise into its suite of tech-enabled managed services, improving data abstraction, reporting, and analytics for healthcare organizations. ERS is a U.S.-based company specializing in cancer registry software and services.
Major players in the disease registry software market are Optum Inc., IQVIA Holdings Inc., Syneos Health Inc., Epic Systems Corporation, Premier Inc., MRO Corp., ImageTrend Inc., Anju Software Inc., BayaTree Inc., Medrio Inc., ArborMetrix Inc., Cedaron Medical Inc., Evado Pty. Ltd., OpenClinica LLC, Dacima Software Inc., Global Vision Technologies Inc., Ordinal Data Inc., Healthmonix LLC, Axis Clinical Software Inc., and Vanderbilt University.
North America was the largest region in the disease registry software market in 2024. The regions covered in disease registry software report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the disease registry software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The disease registry software market includes revenues earned by entities through patient data management, real-time data collection, integration with electronic health records, analytics and reporting, clinical research support, chronic disease management, and public health surveillance. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Disease Registry Software Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on disease registry software market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for disease registry software ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The disease registry software market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Standalone; Integrated
2) By Database: Public; Commercial
3) By Deployment Mode: On-Premises; Cloud-Based
4) By End-User: Hospitals; Government Organizations; Research Centers; Pharmaceutical Companies; Other End Users
Subsegments:
1) By Standalone: Patient Registry Software; Population Health Registry Software; Research Registry Software; Custom Or Single-Disease Registry Software
2) By Integrated: Electronic Health Record (EHR)-Integrated Registry Software; Practice Management System-Integrated Registry Software; Clinical Decision Support (CDS)-Integrated Registry Software; Health Information Exchange (HIE)-Integrated Registry Software
Companies Mentioned: Optum Inc.; IQVIA Holdings Inc.; Syneos Health Inc.; Epic Systems Corporation; Premier Inc.; MRO Corp.; ImageTrend Inc.; Anju Software Inc.; BayaTree Inc.; Medrio Inc.; ArborMetrix Inc.; Cedaron Medical Inc.; Evado Pty. Ltd.; OpenClinica LLC; Dacima Software Inc.; Global Vision Technologies Inc.; Ordinal Data Inc.; Healthmonix LLC; Axis Clinical Software Inc.; Vanderbilt University
3. Disease Registry Software Market Trends And Strategies
4. Disease Registry Software Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Disease Registry Software Growth Analysis And Strategic Analysis Framework
5.1. Global Disease Registry Software PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Disease Registry Software Market Growth Rate Analysis
5.4. Global Disease Registry Software Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Disease Registry Software Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Disease Registry Software Total Addressable Market (TAM)
6. Disease Registry Software Market Segmentation
6.1. Global Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Standalone
Integrated
6.2. Global Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Public
Commercial
6.3. Global Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
On-Premises
Cloud-Based
6.4. Global Disease Registry Software Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Government Organizations
Research Centers
Pharmaceutical Companies
Other End Users
6.5. Global Disease Registry Software Market, Sub-Segmentation Of Standalone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Patient Registry Software
Population Health Registry Software
Research Registry Software
Custom/Single-Disease Registry Software
6.6. Global Disease Registry Software Market, Sub-Segmentation Of Integrated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Electronic Health Record (EHR)-Integrated Registry Software
Practice Management System-Integrated Registry Software
Clinical Decision Support (CDS)-Integrated Registry Software
Health Information Exchange (HIE)-Integrated Registry Software
7. Disease Registry Software Market Regional And Country Analysis
7.1. Global Disease Registry Software Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Disease Registry Software Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
